The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with a history of at…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.